China-Universal-Asset-Management-Co

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-30
Total Holdings
486
Total Value
1074810188
Accession Number
0001906594-25-000002
Form Type
13F-HR
Manager Name
China-Universal-Asset-Management-Co
Data Enrichment
96% identified
465 identified21 unidentified

Holdings

486 positions
Manager:
Search and click to pin securities to the top
Page 20 of 25
Oruka Therapeutics, Inc.
Shares:7.5K
Value:$77.0K
Sana Biotechnology, Inc.
Shares:44.8K
Value:$75.2K
BICYCLE THERAPEUTICS PLC
Shares:8.8K
Value:$75.0K
CorMedix Inc.
Shares:12.2K
Value:$75.0K
EyePoint Pharmaceuticals, Inc.
Shares:13.7K
Value:$74.2K
GALAPAGOS NV
Shares:2.9K
Value:$73.6K
Rapport Therapeutics, Inc.
Shares:7.3K
Value:$73.6K
REGENXBIO Inc.
Shares:9.9K
Value:$71.1K
Stoke Therapeutics, Inc.
Shares:10.6K
Value:$70.7K
Entrada Therapeutics, Inc.
Shares:7.5K
Value:$68.2K
Cartesian Therapeutics, Inc.
Shares:5.1K
Value:$67.2K
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Shares:56.9K
Value:$67.1K
33733E302
Shares:300
Value:$66.6K
33734X192
Shares:650
Value:$66.5K
RIGEL PHARMACEUTICALS INC
Shares:3.5K
Value:$63.6K
MARAVAI LIFESCIENCES HOLDINGS, INC.
Shares:28.5K
Value:$62.9K
Autolus Therapeutics plc
Shares:40.2K
Value:$62.3K
Personalis, Inc.
Shares:17.7K
Value:$62.1K
Allogene Therapeutics, Inc.
Shares:42.1K
Value:$61.4K
Amylyx Pharmaceuticals, Inc.
Shares:17.2K
Value:$60.8K